ES2002053A6 - Procedimiento para la obtencion de peptidos inihiobidores de renina que contienen grupos hidroxi. - Google Patents

Procedimiento para la obtencion de peptidos inihiobidores de renina que contienen grupos hidroxi.

Info

Publication number
ES2002053A6
ES2002053A6 ES8602836A ES8602836A ES2002053A6 ES 2002053 A6 ES2002053 A6 ES 2002053A6 ES 8602836 A ES8602836 A ES 8602836A ES 8602836 A ES8602836 A ES 8602836A ES 2002053 A6 ES2002053 A6 ES 2002053A6
Authority
ES
Spain
Prior art keywords
peptides
chr4
chr3
choh
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8602836A
Other languages
English (en)
Inventor
Peter Raddatz
Gunter Holzemann
Alfred Jonczyk
Claus J Schmitges
Klaus Otto Mick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES2002053A6 publication Critical patent/ES2002053A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE PEPTIDOS INHIBIDORES DE RENINA QUE CONTIENEN GRUPOS HIDROXI DE FORMULA I HX-Z-NR2-CHR3-CHOH-(CHR4)N-CO-EI HEN LA QUE X, Z, R2, R3, R4, E Y N TIENEN EL SIGNIFICADO INDICADO EN LA REIVINDICACION 1, ASI COMO SUS SALES. SE OBTIENEN MEDIANTE SU LIBERACION, A PARTIR DE UNO DE SUS DERIVADOS FUNCIONALES, POR TRATAMIENTO CON UN AGENTE SOLVOLIZANTE O HIDROGENOLIZANTE. LOS COMPUESTOS DE FORMULA I TIENEN ACTIVIDAD DE PLASMARRENINA HUMANA.
ES8602836A 1985-10-31 1986-10-30 Procedimiento para la obtencion de peptidos inihiobidores de renina que contienen grupos hidroxi. Expired ES2002053A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853538749 DE3538749A1 (de) 1985-10-31 1985-10-31 Peptide

Publications (1)

Publication Number Publication Date
ES2002053A6 true ES2002053A6 (es) 1988-07-01

Family

ID=6284924

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8602836A Expired ES2002053A6 (es) 1985-10-31 1986-10-30 Procedimiento para la obtencion de peptidos inihiobidores de renina que contienen grupos hidroxi.

Country Status (10)

Country Link
US (1) US4812555A (es)
EP (1) EP0220665A3 (es)
JP (1) JPS62111956A (es)
AU (1) AU590016B2 (es)
CA (1) CA1283499C (es)
DE (1) DE3538749A1 (es)
ES (1) ES2002053A6 (es)
HU (1) HU205950B (es)
IE (1) IE862862L (es)
ZA (1) ZA868331B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA87563B (en) * 1986-02-03 1987-09-30 Squibb & Sons Inc N-heterocyclic alcohol renin inhibitors
DE3626130A1 (de) * 1986-08-01 1988-02-11 Merck Patent Gmbh Aminosaeurederivate
DE3717631A1 (de) * 1987-05-26 1988-12-15 Merck Patent Gmbh Aminosaeurederivate
US4859654A (en) * 1987-07-01 1989-08-22 Pfizer Inc. Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
EP0297815B1 (en) * 1987-07-01 1994-07-27 Pfizer Inc. Fluorine containing renin inhibitors
EP0297816B1 (en) * 1987-07-01 1994-03-02 Pfizer Inc. Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
US4855303A (en) * 1987-07-01 1989-08-08 Pfizer Inc. Fluorine containing renin inhibitors
EP0304184B1 (en) * 1987-07-31 1994-10-12 Gen-Probe Incorporated Assay for polynucleotides employing oligonucleotides to eliminate undesirable cross reactions
WO1989001488A1 (en) * 1987-08-07 1989-02-23 The Upjohn Company Renin inhibiting peptides with nonpeptide linkages
DE3732971A1 (de) * 1987-09-30 1989-04-20 Hoechst Ag Renin-hemmende dipeptide, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
US5162527A (en) * 1987-10-26 1992-11-10 Warner-Lambert Company Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
KR890701619A (ko) * 1987-10-26 1989-12-22 크리스틴 에이.트러트웨인 레닌 억제제, 그의 제조 방법, 그 사용 방법 및 이들을 함유한 조성물
US5063207A (en) * 1987-10-26 1991-11-05 Warner-Lambert Company Renin inhibitors, method for using them, and compositions containing them
EP0444156A4 (en) * 1988-11-21 1992-12-09 Abbott Laboratories Method for treating vascular diseases
DE3841520A1 (de) * 1988-12-09 1990-06-13 Hoechst Ag Enzymhemmende harnstoffderivate von dipeptiden, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US5212157A (en) * 1989-06-06 1993-05-18 Bio-Mega, Inc. Enzyme inhibitors
US5149692A (en) * 1989-12-21 1992-09-22 Warner-Lambert Company Bisalkoxyphosphinyl compounds as renin inhibitors
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1258748A (en) * 1981-10-08 1989-08-22 Daniel F. Veber Renin inhibitory peptides
US4595677A (en) * 1982-12-03 1986-06-17 Ciba-Geigy Corporation Substituted tetrapeptides
GB8302615D0 (en) * 1983-01-31 1983-03-02 Whipp And Bourne 1975 Ltd Arc splitter plates
DK110285A (da) * 1984-03-12 1985-09-13 Pfizer Polypeptider og polypeptidderivater indeholdende statin eller derivater deraf og farmaceutiske praeparater
US4636491A (en) * 1984-03-27 1987-01-13 Merck & Co., Inc. Renin inhibitory peptides having improved solubility
DE3418491A1 (de) * 1984-05-18 1985-11-21 Merck Patent Gmbh, 6100 Darmstadt Diaminosaeurederivate
EP0163237A3 (en) * 1984-05-29 1988-04-27 Merck & Co. Inc. Di- and tri-peptidal renin inhibitors
EP0184855A3 (en) * 1984-12-14 1989-05-03 Abbott Laboratories Resin inhibiting compounds
CA1290097C (en) * 1985-07-24 1991-10-01 Merck & Co., Inc. Peptide enzyme inhibitors
US4729985A (en) * 1985-08-09 1988-03-08 Pfizer Inc. Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
DE3532035A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Neue n-alkylierte tripeptide, verfahren zu ihrer herstellung, sie enthaltende medikamente und deren verwendung

Also Published As

Publication number Publication date
US4812555A (en) 1989-03-14
HUT45080A (en) 1988-05-30
EP0220665A3 (de) 1989-04-26
EP0220665A2 (de) 1987-05-06
IE862862L (en) 1987-04-30
AU590016B2 (en) 1989-10-26
CA1283499C (en) 1991-04-23
JPS62111956A (ja) 1987-05-22
DE3538749A1 (de) 1987-05-07
HU205950B (en) 1992-07-28
AU6417186A (en) 1987-05-07
ZA868331B (en) 1987-06-24

Similar Documents

Publication Publication Date Title
ES2002053A6 (es) Procedimiento para la obtencion de peptidos inihiobidores de renina que contienen grupos hidroxi.
CS960586A2 (en) Insekticidni a akaricidni prostredek a zpusob vyroby ucinnych latek
ES8802045A1 (es) Procedimiento para la produccion de tiazoles
MY111201A (en) New imidazopyridines
SG49228A1 (en) Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity
EP0177940A3 (en) Hydrazine derivatives and their use
ES8707553A1 (es) Procedimiento para la obtencion de un peptido.
JO1589B1 (en) Ketones (quaternary hydroimidazo (4.1) benzo-diazepine-2) anti-viral
AU588929B2 (en) Amino acid derivatives
EP0249096A3 (de) Reninhemmende Aminosäurederivate
MY132057A (en) Quinoxalinones, a process for their preparation and their use
CA1271748C (en) BENZAZEPINE DERIVATIVES
EP0333000A3 (en) Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
ES8800124A1 (es) Un procedimiento para la preparacion de nuevos compuestos poliprenilicos.
MD970230A (en) Diamine ether diclavulanate and process for preparation thereof
FI860074A0 (fi) Oktahydroindolizinfoereningar anvaendbara som smaertstillande medel.
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
GR3004095T3 (es)
IL107242A0 (en) Derivatives of benzeneborinic acid, preparation thereof and use thereof as synthetic intermediates
ZA951612B (en) Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
ES8707922A1 (es) Un procedimiento para la preparacion de nuevas cicloalcanocarboxanilidas fluoradas.
ES2001577A6 (es) Un procedimiento para preparar compuestos relacionados con espergualina
IE873214L (en) Peptides
ZA891784B (en) Peptides with pharmaceutical activity
ATE41007T1 (de) 2-alkanoyloxypropanderivate, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-10-30

FD1A Patent lapsed

Effective date: 20001204